Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
Experimental Hematology|May 18, 2004
Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate modelNadim Mahmud, Wenxin Pang, Carrington Cobbs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2018
Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation OutcomesMojibade Hassan, Alina Ulezko Antonova, Jian Ming Li, et al.
ACS Nano|May 26, 2016
Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia ActivityShuting Zhao, Lingling Zhang, Jianfeng Han, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcomeDaniel Weisdorf, Sarah Cooley, Steven Devine, et al.
Bone Marrow Transplantation|February 21, 2024
Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United StatesNeel S Bhatt, Christa L Meyer, Lih-Wen Mau, et al.
Bone Marrow Transplantation|June 10, 2021
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host diseaseYngvar Fløisand, Mark A Schroeder, Patrice Chevallier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2019
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)Ravi Vij, Jennifer Le-Rademacher, Kristina Laumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphomaAmy L Hoerr, Feng Gao, Josephine Hidalgo, et al.
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
Pageof 8